Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $36.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective raised by TD Cowen from $30.00 to $36.00 in a research report report published on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock.

ACHC has been the subject of several other reports. Cantor Fitzgerald boosted their price target on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Royal Bank Of Canada increased their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Barclays raised their target price on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $28.69.

Acadia Healthcare Stock Up 4.2%

NASDAQ:ACHC opened at $33.61 on Tuesday. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $34.02. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a market cap of $3.09 billion, a PE ratio of -2.75, a price-to-earnings-growth ratio of 10.76 and a beta of 0.64. The company has a 50-day moving average of $26.60 and a 200 day moving average of $22.38.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts anticipate that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the last quarter. Wells Fargo & Company MN increased its holdings in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd purchased a new position in shares of Acadia Healthcare in the fourth quarter worth about $52,000. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after buying an additional 5,203 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.